ArticleWorld journal of gastroenterology2007
Association of liver cirrhosis related IgA nephropathy with portal hypertension.
Article in World journal of gastroenterology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 27 citations in OpenAlex.
- Clinicopathological analyses of nephrotic syndrome after liver transplantation.Clinical and experimental nephrology · 2026Article
- Renal Dysfunction Across Etiologies of Chronic Liver Disease: A Cross-Sectional Study From a Tertiary Care Center.Cureus · 2026Article
- Article
- Nephrotic syndrome with concurrent effusion from a different cause: A case series.Journal of family medicine and primary care · 2025Article
- Review
- Identification of key candidate genes for IgA nephropathy using machine learning and statistics based bioinformatics models.Scientific reports · 2022Article
- Macroscopic hematuria in a child with portal hypertension: Answers.Pediatric nephrology (Berlin, Germany) · 2021Article
- Steroid therapy is effective for IgA nephropathy after liver transplantation in a pediatric patient.Clinical case reports · 2021Article
- A Case of Hepatic Glomerulosclerosis with Monoclonal IgA1-Case reports in nephrology · 2018Article
- An Attempt to Establish a Common Animal Model for Hepatorenal Fibrosis in Rats.Pathology research international · 2017Article
- IgA Nephropathy in a Patient Presenting with Pseudotumor Cerebri.Case reports in nephrology · 2016Article
- Acute Kidney Injury in Patients with Chronic Liver Disease: A Review.Indian journal of nephrologyReview
- IgA Nephropathy with Wilson's Disease: A Case Report and Literature Review.Indian journal of nephrologyArticle
- Hepatic-associated immunoglobulin-A nephropathy in a child with liver cirrhosis and portal hypertension.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology AssociationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A high incidence of IgA nephropathy has been reported in patients with liver cirrhosis, though, clinically evident nephrotic syndrome is very uncommon. Impaired hepatic clearance of circulating IgA immune complexes and subsequent deposition in renal glomeruli has been considered principally in the pathogenesis of liver cirrhosis associated IgA nephropathy. Here we report on a patient with cryptogenic liver cirrhosis and splenic vein thrombosis, who presented with nephrotic syndrome. Renal biopsy showed findings consistent with IgA nephropathy. Lower endoscopy showed features of portal hypertensive colopathy. Following initiation of propranolol and anticoagulant treatment to reduce portal pressure, a gradual decrease of proteinuria and hematuria to normal range was noted. The potential pathogenetic role of portal hypertension in the development of IgA nephropathy in cirrhotic patients is discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.